Pay in 4 interest-free payments of $6.49 Learn more
Ships within 48 hours · Estimated delivery Aug 12 - Aug 17
CJC-1295 + Ipamorelin is currently listed in 10 mg
"We have access to a number of different resources to help get that price down," Phillips explained
On the dealmaking front, J&J acquired Halda Therapeutics in a $3.05 billion deal that includes Haldas Riptac cell-death platform and its lead candidate HLD-0915, an oral small-molecule therapy targeting metastatic castration-resistant prostate cancer (mCRPC), along with additional RIPTAC-based programs for other solid tumors
3 A refresher on the SELECT trial As a refresher, the SELECT trial represented the first efforts to specifically investigate cardiovascular (CV) endpoints with GLP-1 receptor agonist medications
Under the guidance of experts, the treatment is safe, effective, and tailored to facilitate overall skin wellness
Mood stabilisers had minor effects, probably confounded by their preferential use in mania-prone patients [22]
US$ 26.14
US$ 24.20
US$ 29.55
